Hum. Reprod. Advance Access originally published online on June 17, 2004
Human Reproduction 2004 19(8):1856-1860; doi:10.1093/humrep/deh352
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prostacyclin enhances the implantation and live birth potentials of mouse embryos
1 The University of Texas Health Science Center-Houston, Obstetrics and Gynecology-Division of Reproductive Endocrinology and 2 Obstetrical and Gynecological Associates, Houston, TX 77030, USA
3 To whom correspondence should be addressed at: The University of Texas Health Science Center-Houston, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, 6431 Fannin Street, MSB 3.604, Houston, TX 77030, USA. Email: jaou-chen.huang{at}uth.tmc.edu
BACKGROUND: Recently we reported that iloprost, a stable analogue of prostacyclin, enhanced mouse embryo hatching. Here we present a follow-up study to determine whether exposure to iloprost augments the implantation and live birth potentials of mouse embryos. METHODS: Two-cell embryos (C3B6F1) were harvested 42 h after HCG injection and cultured in medium supplemented with iloprost. After 48 h, the embryos were transferred to 2.5 day pseudopregnant gestational carriers. The number of gestation sacs was counted 72 h later; the number of live pups and the weight of pups and placentae were determined 14 days later. The implantation rate was defined as gestation sac per embryo transferred; the live birth rate was defined as live pup per embryo transferred. RESULTS: The prostacyclin analogue enhanced the implantation rate from 42 to 76% [relative risk 1.84, 95% confidence interval (CI) 1.382.43]. The rate of live pups also increased from 28 to 36% (relative risk 1.28, 95% CI 1.041.56). The weights of the pups and of the placentae of the two groups were comparable. CONCLUSION: Prostacyclin enhances the potentials of implantation and live birth of mouse embryos.
Key words: cyclooxygenase/embryotrophic factor/prostaglandin
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J.-C. Huang, W.-S. A. Wun, J. S. Goldsby, K. Egan, G. A. FitzGerald, and K. K. Wu Prostacyclin receptor signaling and early embryo development in the mouse Hum. Reprod., November 1, 2007; 22(11): 2851 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Huang, W.-S.A. Wun, J.S. Goldsby, I.C. Wun, D. Noorhasan, and K.K. Wu Stimulation of embryo hatching and implantation by prostacyclin and peroxisome proliferator-activated receptor {delta} activation: implication in IVF Hum. Reprod., March 1, 2007; 22(3): 807 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yu, J. Fan, Y. Hui, C. A. Rouzer, L. J. Marnett, A. J. Klein-Szanto, G. A. FitzGerald, and C. D. Funk Targeted Cyclooxygenase Gene (Ptgs) Exchange Reveals Discriminant Isoform Functionality J. Biol. Chem., January 12, 2007; 282(2): 1498 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wanggren, P.G. Lalitkumar, A. Stavreus-Evers, B. Stabi, and K. Gemzell-Danielsson Prostaglandin E2 and F2{alpha} receptors in the human Fallopian tube before and after mifepristone treatment Mol. Hum. Reprod., September 1, 2006; 12(9): 577 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Huang, W.-S.A. Wun, J. S. Goldsby, N. Matijevic-Aleksic, and K. K. Wu Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching Hum. Reprod., December 1, 2004; 19(12): 2900 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Huang, J. S. Goldsby, F. Arbab, Z. Melhem, N. Aleksic, and K. K. Wu Oviduct prostacyclin functions as a paracrine factor to augment the development of embryos Hum. Reprod., December 1, 2004; 19(12): 2907 - 2912. [Abstract] [Full Text] [PDF] |
||||


